Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis

Abstract

Lower plasma sRAGE levels may be a biological measure of disease severity in IPF. Variation at the rs2070600 single-nucleotide polymorphism was not associated with IPF risk.